Health and Wealth 247

On the front page of its Business Day section, the New York Times (7/29, B1, Singer, Schmidt) reports that the FDA “warned consumers on Tuesday not to use body-building products that are sold as nutritional supplements but may contain steroids or steroidlike substances, citing reports of acute liver injury and kidney failure.” Prompted by “increased reports of medical problems in men who had used such products,” the alert named “eight specific supplements sold by a single company,” but “did not provide much clear guidance to consumers on what other products to avoid. The FDA acknowledged that it did not know how many products its warning affects. Generally, the FDA said, buyers should beware of body-building products that claim to enhance or diminish the effects of hormones like testosterone, estrogen or progestin.”

The AP (7/29, Pells) notes that the warning “came five days after FDA investigators, led by Jeff Novitzky of the BALCO probe, raided the California offices of American Cellular Labs, looking for evidence the company sells steroids under the guise of a supplement. The FDA sent a warning letter to the company, saying it was selling unapproved and misbranded drugs and telling the company to explain how it was going to ‘prevent the recurrence of violations.’” The AP lists the products in question, adding, “Though most high-level athletes in testing programs would test positive for taking these products, they are thought to be popular among athletes in high school, especially football players, most of whom aren’t subjected to as thorough a drug-testing program.” The New York Daily News (7/29, Red) also covers the story.

Experience an all natural amino stack – SomaLife’s gHP Sport – risk free!